Samanvi Institute Of Dermatological Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
as on 04-01-2025
- Revenue 76.27%
(FY 2022)
- Profit -30.38%
(FY 2022)
- Ebitda -3.54%
(FY 2022)
- Net Worth 18.09%
(FY 2022)
- Total Assets -10.94%
(FY 2022)
About Samanvi Institute Of Dermatological Sciences
The Corporate was formerly known as Samanvi Institute Of Dermalogical Sciences Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Sreenath Chinnapolla and Pothuru Usha serve as directors at the Company.
- CIN/LLPIN
U85100TG2018PTC123189
- Company No.
123189
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samanvi Institute Of Dermatological Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenath Chinnapolla  | Director | 21-Mar-2018 | Current |
| Pothuru Usha | Director | 21-Mar-2018 | Current |
Financial Performance of Samanvi Institute Of Dermatological Sciences.
Samanvi Institute Of Dermatological Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 76.27% increase. The company also saw a substantial fall in profitability, with a 30.38% decrease in profit. The company's net worth Soared by an impressive increase of 18.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samanvi Institute Of Dermatological Sciences?
In 2022, Samanvi Institute Of Dermatological Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2024 | ₹7.00 M | Open |
How Many Employees Work at Samanvi Institute Of Dermatological Sciences?
Unlock and access historical data on people associated with Samanvi Institute Of Dermatological Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samanvi Institute Of Dermatological Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samanvi Institute Of Dermatological Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.